Amgen declares $2.52 dividend
2026-03-04 16:25:12 ET
More on Amgen
- Amgen Inc. (AMGN) Presents at TD Cowen 46th Annual Health Care Conference Transcript
- Amgen Inc. (AMGN) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript
- Amgen Inc. (AMGN) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium Transcript
- CVS Health to swap Amgen and Lilly’s bone drugs with biosimilars in commercial formularies
- Amgen outlines $37B–$38.4B 2026 revenue target as Repatha, EVENITY, and TEZSPIRE drive momentum
Read the full article on Seeking Alpha
For further details see:
Amgen declares $2.52 dividendNASDAQ: AMGN
AMGN Trading
2.31% G/L:
$374.045 Last:
853,910 Volume:
$368.27 Open:



